Endogenously nitrated proteins in mouse brain: Links to neurodegenerative disease

Biochemistry

Volumn 45, Issue 26, 2006, Pages 8009-8022

  Sacksteder, Colette A ^a   Qian, Wei Jun ^a   Knyushko, Tatyana V ^a   Wang, Haixing ^a   Chin, Mark H ^b   Lacan, Goran ^b   Melega, William P ^b   Camp II, David G ^a   Smith, Richard D ^a   Smith, Desmond J ^b   Squier, Thomas C ^a   Bigelow, Diana J ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGY; METABOLISM; NEUROLOGY; NITRATES; PATHOLOGY; PROTEINS; TISSUE;

ALZHEIMER'S DISEASE; METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP); NEURODEGENERATIVE DISORDERS; PARKINSON'S DISEASE;

DISEASES;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 NITROTYROSINE; AMINO ACID; CYSTEINE; METHIONINE; PEROXYNITRITE; PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MODEL; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MOUSE; MOUSE STRAIN; NITRATION; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEOMICS; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CAPILLARITY; CHROMATOGRAPHY, LIQUID; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NITRATES; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEOME;

ANIMALIA;

EID: 33745611162     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi060474w     Document Type: Article

References (122)

1. Shishehbor, M. H., Aviles, R. J., Brennan, M. L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, J. F., Jr., Penn, M. S., Sprecher, D. L., Vita, J. A., and Hazen, S. L. (2003) Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy, JAMA, J. Am. Med. Assoc. 289, 1675-80.
2. Ara, J., Przedborski, S., Naini, A. B., Jackson-Lewis, V., Trifiletti, R. R., Horwitz, J., and Ischiropoulos, H. (1998) Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Proc. Natl. Acad. Sci. U.S.A. 95, 7659-63.
3. Newman, D. K., Hoffman, S., Kotamraju, S., Zhao, T., Wakim, B., Kalyanaraman, B., and Newman, P. J. (2002) Nitration of PECAM-I ITIM tyrosines abrogates phosphorylation and SHP-2 binding, Biochem. Biophys. Res. Commun. 296, 1171-9.
4. Di Stasi, A. M., Mallozzi, C., Macchia, G., Petrucci, T. C., and Minetti, M. (1999) Peroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins, J. Neurochem. 73, 727-35.
5. Koeck, T., Levison, B., Hazen, S. L., Crabb, J. W., Stuehr, D. J., and Aulak, K. S. (2004) Tyrosine nitration impairs mammalian aldolase A activity, Mol. Cell. Proteomics 3, 548-57.
6. Li, X., De Sarno, P., Song, L., Beckman, J. S., and Jope, R. S. (1998) Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: Attenuated effects in human 1321N1 astrocytoma cells, Biochem. J. 331 (Part 2), 599-606.
7. Mallozzi, C., Di Stasi, A. M., and Minetti, M. (2001) Nitrotyrosine mimics phosphotyrosine binding to the SH2 domain of the src family tyrosine kinase lyn, FEBS Lett. 503, 189-95.
8. Knyushko, T. V., Sharov, V. S., Williams, T. D., Schoneich, C., and Bigelow, D. J. (2005) 3-Nitrotyrosine Modification of SERCA2a in the Aging Heart: A Distinct Signature of the Cellular Redox Environment, Biochemistry 44, 13071-81.
9. 2+-ATPase in skeletal muscle, Biochem. J. 340 (Part 3), 657-69.
10. Beckman, J. S., and Koppenol, W. H. (1996) Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly, Am. J. Physiol. 271, C1424-37.
11. Reiter, C. D., Teng, R. J., and Beckman, J. S. (2000) Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite, J. Biol. Chem. 275, 32460-6.
12. Tien, M., Berlett, B. S., Levine, R. L., Chock, P. B., and Stadtman, E. R. (1999) Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentration: pH dependence of carbonyl formation, tyrosine nitration, and methionine oxidation, Proc. Natl. Acad. Sci. U.S.A. 96, 7809-14.
13. Kooy, N. W., Lewis, S. J., Royall, J. A., Ye, Y. Z., Kelly, D. R., and Beckman, J. S. (1997) Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite, Crit. Care Med. 25, 812-9.
14. Brennan, M. L., Wu, W., Fu, X., Shen, Z., Song, W., Frost, H., Vadseth, C., Narine, L., Lenkiewicz, E., Borchers, M. T., Lusis, A. J., Lee, J. J., Lee, N. A., Abu-Soud, H. M., Ischiropoulos, H., and Hazen, S. L. (2002) A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species, J. Biol. Chem. 277, 17415-27.
15. Koeck, T., Fu, X., Hazen, S. L., Crabb, J. W., Stuehr, D. J., and Aulak, K. S. (2004) Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria, J. Biol. Chem. 279, 27257-62.
16. Adachi, T., Weisbrod, R. M., Pimentel, D. R., Ying, J., Sharov, V. S., Schoneich, C., and Cohen, R. A. (2004) S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide, Nat. Med. 10, 1200-7.
17. Liu, T., Qian, W. J., Chen, W. N., Jacobs, J. M., Moore, R. J., Anderson, D. J., Gritsenko, M. A., Monroe, M. E., Thrall, B. D., Camp, D. G., II, and Smith, R. D. (2005) Improved proteome coverage by using high efficiency cysteinyl peptide enrichment: The human mammary epithelial cell proteome, Proteomics 5, 1263-73.
18. Qian, W. J., Liu, T., Monroe, M. E., Strittmatter, E. F., Jacobs, J. M., Kangas, L. J., Petritis, K., Camp, D. G., II, and Smith, R. D. (2005) Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: The human proteome, J. Proteome Res. 4, 53-62.
19. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry, Anal. Chem. 75, 4646-58.
20. Al-Shahrour, F., Diaz-Uriarte, R., and Dopazo, J. (2004) FatiGO: A web tool for finding significant associations of Gene Ontology terms with groups of genes, Bioinformatics 20, 578-80.
21. Qian, W. J., Jacobs, J. M., Camp, D. G., II, Monroe, M. E., Moore, R. J., Gritsenko, M. A., Galvano, S. E., Lowry, S. F., Xiao, W., Moldawer, L. L., Davis, R. W., Tompkins, R. G., and Smith, R. D. (2005) Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry, Proteomics 5, 572-84.
22. Krogh, A., Larsson, B., von Heijne, G., and Sonnhammer, E. L. (2001) Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes, J. Mol. Biol. 305, 567-80.
23. Wang, H., Qian, W. J., Chin, M. H., Petyuk, V. A., Barry, R. C., Liu, T., Gritsenko, M. A., Mottaz, H. M., Moore, R. J., Camp, D. G., II, Khan, A. H., Smith, D. J., and Smith, R. D. (2006) Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment, J. Proteome Res. 5, 361-9.
24. Ischiropoulos, H. (2003) Biological selectivity and functional aspects of protein tyrosine nitration, Biochem. Biophys. Res. Commun. 305, 776-83.
25. Zhan, X., and Desiderio, D. M. (2004) The human pituitary nitroproteome: Detection of nitrotyrosyl-proteins with two-dimensional Western blotting, and amino acid sequence determination with mass spectrometry, Biochem. Biophys. Res. Commun. 325, 1180-6.
26. Kanski, J., Hong, S. J., and Schoneich, C. (2005) Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nano-electrospray ionization tandem mass spectrometry, J. Biol. Chem. 280, 24261-6.
27. Kanski, J., Behring, A., Felling, J., and Schoneich, C. (2005) Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: Effects of biological aging, Am. J. Physiol. 288, H371-81.
28. Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B., Markesbery, W. R., and Butterfield, D. A. (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain, J. Neurochem. 85, 1394-401.
29. Mihm, M. J., Coyle, C. M., Schanbacher, B. L., Weinstein, D. M., and Bauer, J. A. (2001) Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure, Cardiovasc. Res. 49, 798-807.
30. Fiore, G., Cristo, C. D., Monti, G., Amoresano, A., Columbano, L., Pucci, P., Cioffi, F. A., Cosmo, A. D., Palumbo, A., and d'Ischia, M. (2006) Tubulin nitration in human gliomas, Neurosci. Lett. 394, 57-62.
31. Banan, A., Zhang, L. J., Shaikh, M., Fields, J. Z., Farhadi, A., and Keshavarzian, A. (2004) Novel effect of NF-κB activation: Carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium, Am. J. Physiol. 287, C1139-51.
32. Bolan, E. A., Gracy, K. N., Chan, J., Trifiletti, R. R., and Pickel, V. M. (2000) Ultrastructural localization of nitrotyrosine within the caudate-putamen nucleus and the globus pallidus of normal rat brain, J. Neurosci. 20, 4798-808.
33. Han, D., Antunes, F., Canali, R., Rettori, D., and Cadenas, E. (2003) Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol, J. Biol. Chem. 278, 5557-63.
34. Cadenas, E. (2004) Mitochondrial free radical production and cell signaling, Mol. Aspects Med. 25, 17-26.
35. Wagner, O. I., Lifshitz, J., Janmey, P. A., Linden, M., McIntosh, T. K., and Leterrier, J. F. (2003) Mechanisms of mitochondria-neurofilament interactions, J. Neurosci. 23, 9046-58.
36. Anantharaman, M., Tangpong, J., Keller, J. N., Murphy, M. P., Markesbery, W. R., Kiningham, K. K., and St Clair, D. K. (2006) β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase: Implication for Oxidative Stress in a APPNLh/NLh × PS-1P264L/P264L Double Knock-In Mouse Model of Alzheimer's Disease, Am. J. Pathol. 168, 1608-18.
37. Mehl, M., Bidmon, H. J., Hilbig, H., Zilles, K., Dringen, R., and Ullrich, V. (1999) Prostacyclin synthase is localized in rat, bovine and human neuronal brain cells, Neurosci. Lett. 271, 187-90.
38. Zou, M., Martin, C., and Ullrich, V. (1997) Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite, Biol. Chem. 378, 707-13.
39. Yamin, G., Uversky, V. N., and Fink, A. L. (2003) Nitration inhibits fibrillation of human α-synuclein in vitro by formation of soluble oligomers, FEBS Lett. 542, 147-52.
40. Duda, J. E., Giasson, B. I., Chen, Q., Our, T. L., Hurtig, H. I., Stern, M. B., Gollomp, S. M., Ischiropoulos, H., Lee, V. M., and Trojanowski, J. Q. (2000) Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies, Am. J. Pathol. 157, 1439-45.
41. He, K., Nukada, H., McMorran, P. D., and Murphy, M. P. (1999) Protein carbonyl formation and tyrosine nitration as markers of oxidative damage during ischaemia-reperfusion injury to rat sciatic nerve, Neuroscience 94, 909-16.
42. Barreiro, E., Comtois, A. S., Gea, J., Laubach, V. E., and Hussain, S. N. (2002) Protein tyrosine nitration in the ventilatory muscles: Role of nitric oxide synthases, Am. J. Respir. Cell Mol. Biol. 26, 438-46.
43. Bloem, B. R., Irwin, I., Buruma, O. J., Haan, J., Roos, R. A., Tetrud, J. W., and Langston, J. W. (1990) The MPTP model: Versatile contributions to the treatment of idiopathic Parkinson's disease, J. Neurol. Sci. 97, 273-93.
44. Pennathur, S., Jackson-Lewis, V., Przedborski, S., and Heinecke, J. W. (1999) Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease, J. Biol. Chem. 274, 34621-8.
45. Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., and Perry, G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci. 17, 2653-7.
46. 2-: EPR SPIN trapping studies, J. Biol. Chem. 280, 40684-98.
47. Ischiropoulos, H. (1998) Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species, Arch. Biochem. Biophys. 356, 1-11.
48. Smallwood, H. S., Galeva, N. A., Bartlett, R. K., Urbauer, R. J., Williams, T. D., Urbauer, J. L., and Squier, T. C. (2003) Selective nitration of Tyr99 in calmodulin as a marker of cellular conditions of oxidative stress, Chem. Res. Toxicol. 16, 95-102.
49. Souza, J. M., Daikhin, E., Yudkoff, M., Raman, C. S., and Ischiropoulos, H. (1999) Factors determining the selectivity of protein tyrosine nitration, Arch. Biochem. Biophys. 371, 169-78.
50. Aulak, K. S., Miyagi, M., Yan, L., West, K. A., Massillon, D., Crabb, J. W., and Stuehr, D. J. (2001) Proteomic method identifies proteins nitrated in vivo during inflammatory challenge, Proc. Natl. Acad. Sci. U.S.A. 98, 12056-61.
51. Turko, I. V., Li, L., Aulak, K. S., Stuehr, D. J., Chang, J. Y., and Murad, F. (2003) Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes, J. Biol. Chem. 278, 33972-7.
52. Wu, C. C., and Yates, J. R., III (2003) The application of mass spectrometry to membrane proteomics, Nat. Biotechnol. 21, 262-7.
53. Brown, M. D., Trounce, I. A., Jun, A. S., Allen, J. C., and Wallace, D. C. (2000) Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation, J. Biol. Chem. 275, 39831-6.
54. Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., Wallace, D. C., and Rabinovitch, P. S. (2005) Extension of murine life span by overexpression of catalase targeted to mitochondria, Science 308, 1909-11.
55. Ghafourifar, P., and Colton, C. A. (2003) Compartmentalized nitrosation and nitration in mitochondria, Antioxid. Redox Signaling 5, 349-54.
56. Koeck, T., Stuehr, D. J., and Aulak, K. S. (2005) Mitochondria and regulated tyrosine nitration, Biochem. Soc. Trans. 33, 1399-403.
57. Yamamoto, T., Maruyama, W., Kato, Y., Yi, H., Shamoto-Nagai, M., Tanaka, M., Sato, Y., and Naoi, M. (2002) Selective nitration of mitochondrial complex I by peroxynitrite: Involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells, J. Neurol. Transm. 109, 1-13.
58. Aksenova, M. V., Aksenov, M. Y., Payne, R. M., Trojanowski, J. Q., Schmidt, M. L., Carney, J. M., Butterfield, D. A., and Markesbery, W. R. (1999) Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders, Dementia Geriatr. Cognit. Disord. 10, 158-65.
59. Bonnet, R., Pavlovic, S., Lehmann, J., and Rommelspacher, H. (2004) The strong inhibition of triosephosphate isomerase by the natural β-carbolines may explain their neurotoxic actions, Neuroscience 127, 443-53.
60. Olah, J., Orosz, F., Keseru, G. M., Kovari, Z., Kovacs, J., Hollan, S., and Ovadi, J. (2002) Triosephosphate isomerase deficiency: A neurodegenerative misfolding disease, Biochem. Soc. Trans. 30, 30-8.
61. Olah, J., Orosz, F., Puskas, L. G., Hackler, L., Jr., Horanyi, M., Polgar, L., Hollan, S., and Ovadi, J. (2005) Triosephosphate isomerase deficiency: Consequences of an inherited mutation at mRNA, protein and metabolic levels, Biochem. J. (in press).
62. Meriin, A. B., and Sherman, M. Y. (2005) Role of molecular chaperones in neurodegenerative disorders, Int. J. Hyperthermia 27, 403-19.
63. Morris, C. M., Kadish, I., Blalock, E. M., Chen, K. C., Thibault, V., Porter, N. M., Landfield, P. W., and Kraner, S. D. (2005) Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models, J. Neurosci. 25, 4649-58.
64. Agbas, A., Zaidi, A., and Michaelis, E. K. (2005) Decreased activity and increased aggregation of brain calcineurin during aging, Brain Res. 1059, 59-71.
65. Fern, A., Nencini, M., Battistini, S., Giannini, F., Siciliano, G., Casali, C., Damiano, M. G., Ceroni, M., Chio, A., Rotilio, G., and Carri, M. T. (2004) Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients, J. Neurochem. 90, 1237-42.
66. Peng, X. M., Tehranian, R., Dietrich, P., Stefanis, L., and Perez, R. G. (2005) α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells, J. Cell Sci. 118, 3523-30.
67. Uversky, V. N., Yamin, G., Munishkina, L. A., Karymov, M. A., Millett, I. S., Doniach, S., Lyubchenko, Y. L., and Fink, A. L. (2005) Effects of nitration on the structure and aggregation of α-synuclein, Brain Res. Mol. Brain Res. 134, 84-102.
68. Przedborski, S., Chen, Q., Vila, M., Giasson, B. I., Djaldatti, R., Vukosavic, S., Souza, J. M., Jackson-Lewis, V., Lee, V. M., and Ischiropoulos, H. (2001) Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease, J. Neurochem. 76, 637-40.
69. Brandt, R. (2001) Cytoskeletal mechanisms of neuronal degeneration, Cell Tissue Res. 305, 255-65.
70. Tedeschi, G., Cappelletti, G., Negri, A., Pagliato, L., Maggioni, M. G., Maci, R., and Ronchi, S. (2005) Characterization of nitroproteome in neuron-like PC12 cells differentiated with nerve growth factor: Identification of two nitration sites in α-tubulin, Proteomics 5, 2422-32.
71. Casoni, F., Basso, M., Massignan, T., Gianazza, E., Cheroni, C., Salmona, M., Bendotti, C., and Bonetto, V. (2005) Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: Possible multifunctional role in the pathogenesis, J. Biol. Chem. 280, 16295-304.
72. + neurotoxicity on NGF-differentiated PC12 cells, Cell Biol. Int. 19, 687-93.
73. De Iuliis, A., Grigoletto, J., Recchia, A., Giusti, P., and Arslan, P. (2005) A proteomic approach in the study of an animal model of Parkinson's disease, Clin. Chim. Acta 357, 202-9.
74. Ren, Y., Zhao, J., and Feng, J. (2003) Parkin binds to α/β tubulin and increases their ubiquitination and degradation, J. Neurosci. 23, 3316-24.
75. Beckman, J. S. (2002) Protein tyrosine nitration and peroxynitrite, FASEB J. 16, 1144.
76. Go, Y. M., Patel, R. P., Maland, M. C., Park, H., Beckman, J. S., Darley-Usmar, V. M., and Jo, H. (1999) Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH2-terminal kinase, Am. J. Physiol. 277, H1647-53.
77. Park, S. W., Huq, M. D., Hu, X., and Wei, L. N. (2005) Tyrosine nitration on p65: A novel mechanism to rapidly inactivate nuclear factor-κB, Mol. Cell. Proteomics 4, 300-9.
78. Bigelow, D. J., and Squier, T. C. (2005) Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins, Biochim. Biophys. Acta 1703, 121-34.
79. Santos, C. X., Bonini, M. G., and Augusto, O. (2000) Role of the carbonate radical anion in tyrosine nitration and hydroxylation by peroxynitrite, Arch. Biochem. Biophys. 377, 146-52.
80. Zhang, Z., Oliver, P., Lancaster, J. J., Schwarzenberger, P. O., Joshi, M. S., Cork, J., and Kolls, J. K. (2001) Reactive oxygen species mediate tumor necrosis factor α-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate, FASEB J. 15, 303-5.
81. Kingsbury, A. E., Cooper, M., Schapira, A. H., and Foster, O. J. (2001) Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: An in situ hybridization study, Ann. Neurol. 50, 142-9.
82. Kim, T. D., Paik, S. R., Yang, C. H., and Kim, J. (2000) Structural changes in α-synuclein affect its chaperone-like activity in vitro, Protein Sci. 9, 2489-96.
83. Riemenschneider, M., Buch, K., Schmolke, M., Kurz, A., and Guder, W. G. (1997) Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase, Lancet 350, 784.
84. Perluigi, M., Poon, H. F., Maragos, W., Pierce, W. M., Klein, J. B., Calabrese, V., Cini, C., De Marco, C., and Butterfield, D. A. (2005) Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice: A model of Huntington's disease, Mol. Cell. Proteomics 4, 1849-61.
85. Dolder, M., Walzel, B., Speer, O., Schlattner, U., and Wallimann, T. (2003) Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation, J. Biol. Chem. 278, 17760-6.
86. Andres, R. H., Huber, A. W., Schlattner, U., Perez-Bouza, A., Krebs, S. H., Seiler, R. W., Wallimann, T., and Widmer, H. R. (2005) Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue, Neuroscience 133, 701-13.
87. Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., and Beal, M. F. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, Nat. Med. 5, 347-50.
88. Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., and Beal, M. F. (1999) Creatine and cyclocreatine attenuate MPTP neurotoxicity, Exp. Neurol. 157, 142-9.
89. Gelbard, H. A. (2004) Synapses and Sisyphus: Life without paraplegin, J. Clin. Invest. 113, 185-7.
90. Lindholm, D., Eriksson, O., and Korhonen, L. (2004) Mitochondrial proteins in neuronal degeneration, Biochem. Biophys. Res. Commun. 321, 753-8.
91. Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., and Hayflick, S. J. (2001) A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome, Nat. Genet. 28, 345-9.
92. Hata, R., Masumura, M., Akatsu, H., Li, F., Fujita, H., Nagai, Y., Yamamoto, T., Okada, H., Kosaka, K., Sakanaka, M., and Sawada, T. (2001) Up-regulation of calcineurin Aβ mRNA in the Alzheimer's disease brain: Assessment by cDNA microarray, Biochem. Biophys. Res. Commun. 284, 310-6.
93. Chang, R. C., Wong, A. K., Ng, H. K., and Hugon, J. (2002) Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimer's disease, NeuroReport 13, 2429-32.
94. Tan, S., Somia, N., Maher, P., and Schubert, D. (2001) Regulation of antioxidant metabolism by translation initiation factor 2α, J. Cell Biol. 152, 997-1006.
95. Holtz, W. A., and O'Malley, K. L. (2003) Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons, J. Biol. Chem. 278, 19367-77.
96. Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., and Piomelli, D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation, Proc. Natl. Acad. Sci. U.S.A. 99, 10819-24.
97. Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Walker, J. M., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia, Nature 435, 1108-12.
98. van der Stell, M., Fox, S. H., Hill, M., Crossman, A. R., Petrosino, S., Di Marzo, V., and Brotchie, J. M. (2005) A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease, FASEB J. 19, 1140-2.
99. Delgado, M., and Ganea, D. (2003) Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: Potential therapeutic role in brain trauma, FASEB J. 17, 1922-4.
100. Hald, A., and Lotharius, J. (2005) Oxidative stress and inflammation in Parkinson's disease: Is there a causal link? Exp. Neurol. 193, 279-90.
101. Cuadrado-Tejedor, M., Sesma, M. T., Gimenez-Amaya, J. M., and Ortiz, L. (2005) Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice, Neurobiol. Dis. (in press).
102. Boutte, A. M., Neely, M. D., Bird, T. D., Montine, K. S., and Montine, T. J. (2005) Diminished taxol/GTP-stimulated tubulin polymerization in diseased region of brain from patients with late-onset or inherited Alzheimer's disease or frontotemporal dementia with parkinsonism linked to chromosome-17 but not individuals with mild cognitive impairment, J. Alzheimer's Dis. 8, 1-6.
103. Chande, M. (2003) Defects in tubulin assembly machinery underlie disease, Lancet Oncol. 4, 67.
104. Suwelack, D., Hurtado-Lorenzo, A., Millan, E., Gonzalez-Nicolini, V., Wawrowsky, K., Lowenstein, P. R., and Castro, M. G. (2004) Neuronal expression of the transcription factor Gli 1 using the Tα1 α-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease, Gene Ther. 11, 1742-52.
105. Irwin, S., Vandelft, M., Pinchev, D., Howell, J. L., Graczyk, J., Orr, H. T., and Truant, R. (2005) RNA association and nucleocytoplasmic shuttling by ataxin-1, J. Cell Sci. 118, 233-42.
106. Blom, N., Gammeltoft, S., and Brunak, S. (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites, J. Mol. Biol. 294, 1351-62.
107. Kreegipuu, A., Blom, N., and Brunak, S. (1999) PhosphoBase, a database of phosphorylation sites: Release 2.0, Nucleic Acids Res. 27, 237-9.
108. Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., and Bairoch, A. (2005) Protein Identification and Analysis Tools on ExPASy Server, Humana Press, Totowa, NJ.
109. Kyte, J., and Doolittle, R. F. (1982) A simple method for displaying the hydropathic character of a protein, J. Mol. Biol. 157, 105-32.
110. Sayle, R. A., and Milner-White, E. J. (1995) RASMOL: Biomolecular graphics for all, Trends Biochem. Sci. 20, 374.
111. Tsodikov, O. V., Record, M. T., Jr., and Sergeev, Y. V. (2002) Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature, J. Comput. Chem. 23, 600-9.
112. Worle, M., Latal, P., Kissner, R., Nesper, R., and Koppenol, W. H. (1999) Conformation of peroxynitrite: Determination by crystallographic analysis, Chem. Res. Toxicol. 12, 305-7.
113. Blom, N., and Sygusch, J. (1997) Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase, Nat. Struct. Biol. 4, 36-9.
114. McPhalen, C. A., Vincent, M. G., Picot, D., Jansonius, J. N., Lesk, A. M., and Chothia, C. (1992) Domain closure in mitochondrial aspartate aminotransferase, J. Mol. Biol. 227, 197-213.
115. Chik, J. K., Lindberg, U., and Schutt, C. E. (1996) The structure of an open state of β-actin at 2.65 Å resolution, J. Mol. Biol. 263, 607-23.
116. Kissinger, C. R., Parge, H. E., Knighton, D. R., Lewis, C. T., Pelletier, L. A., Tempczyk, A., Kalish, V. J., Tucker, K. D., Showalter, R. E., Moomaw, E. W., et al. (1995) Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex, Nature 378, 641-4.
117. Heldwein, E. E., Macia, E., Wang, J., Yin, H. L., Kirchhausen, T., and Harrison, S. C. (2004) Crystal structure of the clathrin adaptor protein 1 core, Proc. Natl. Acad. Sci. U.S.A. 101, 14108-13.
118. Eder, M., Schlattner, U., Becker, A., Wallimann, T., Kabsch, W., and Fritz-Wolf, K. (1999) Crystal structure of brain-type creatine kinase at 1.41 Å resolution, Protein Sci. 8, 2258-69.
119. Fritz-Wolf, K., Schnyder, T., Wallimann, T., and Kabsch, W. (1996) Structure of mitochondrial creatine kinase, Nature 381, 341-5.
120. Kursula, I., Salin, M., Sun, J., Norledge, B. V., Haapalainen, A. M., Sampson, N. S., and Wierenga, R. K. (2004) Understanding protein lids: Structural analysis of active hinge mutants in triosephosphate isomerase, Protein Eng., Des. Sel. 17, 375-82.
121. Nogales, E., Wolf, S. G., and Downing, K. H. (1998) Structure of the αβ tubulin dimer by electron crystallography, Nature 391, 199-203.
122. Bernstein, F. C., Koetzle, T. F., Williams, G. J., Meyer, E. F., Jr., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., and Tasumi, M. (1977) The Protein Data Bank. A computer-based archival file for macromolecular structures, Eur. J. Biochem. 80, 319-24.